Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Lol must say DuncH is very persistent with posting his crap!
Lol Dunc tried his utter best, talking of £2 etc. Fundamentals are fundamentals end of the day, this should never have reached £2.50
How's it looking in France?
Ticking up now with 260p trades!
Amryt has a market cap of $723m (circa £523m), would they be able to afford to takeover NCYT at say £5+ a share meaning around 360m + market cap...
Where can the BlackRock buying be found?
Great tweet by Novacyt , public will be able to book Covid tests at Heathrow Airport from Monday!
Where is this info?
99.9%
Haha any lower and the market cap will be worth less than what they are actually worth!
The market in general is down today, there is no specific reason for Nova to be down.
At such a ridiculously low price I am not surprised the slightest! Great opportunity to lower the average at this bargain price.
Got better things to do then waste time on Dunc, would advise to ignore him.
I think with Q3 results due anytime and a promising winter with DA taking over, we are in for a treat!
Agreed, I don't think the DHSC would want the litigation to reach court, not great PR for them nor the Conservative led Government. They've been a shambles after shambles with their purchase of unused PPR kits, cheap Chinese tests, not locking down earlier last winter, their MPs abusing positions and handing out contracts to their fellow Tory pals.
couldn't agree more larry, wouldn't trust greedy Dunc one bit, sole intention to buy lower and create fear amongst everyone
The fact we have been given the latest DHSC contract of circa £5m means the relationship is intact otherwise we would not have been awarded it, I believe the dispute can be resolved amicably by both parties.
Wouldn't be surprised if we see a bidding war starts once dispute has been resolved. We already have good partnerships with the likes of AstraZeneca and maybe Pfizer as we expand in the US...
Unnecessary post alamo, keep your negativity away
The short term frustration should not let anyone blind side the fundamentals, the fundamentals are there and we are expanding internationally, the DHSC is no longer our main stream of income, non DHSC sales increased by 20% in H1 and H2 is only expected to increase further. With immunity from the first 2 doses of vaccine running out/low and booster program starting, there is a risk for certain age groups to become vulnerable again and testing to be paramount for the economy and country to continue some "normality"
US expansion and contracts with UNICEF and WHO until summer 2022 along with the latest DHSC contract will generate income. With cases expected to rise over the winter, employers wanting employees to return, schools/Universities back, travel and entertainment industry wanting to pick up - testing demand will be very high! We have the PCR products and having the expected LFT products covers us on both sides of testing. Hospitals are still averaging 7,000 patients a day which is likely to increase over the winter. PROmate is still in demand across hospital trusts.